The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 04, 2018
Filed:
Mar. 18, 2016
Applicant:
Valcuria Ab, Lund, SE;
Inventors:
Kristina Drott, Lund, SE;
Thomas Relander, Lund, SE;
Assignee:
VALCURIA AB, Lund, SE;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/573 (2006.01); A61K 31/167 (2006.01); A61K 31/165 (2006.01); A61K 45/06 (2006.01); A61K 38/07 (2006.01); A61K 38/12 (2006.01); A61K 31/18 (2006.01); A61K 31/19 (2006.01); A61K 31/404 (2006.01); A61K 31/437 (2006.01); A61K 31/4402 (2006.01); A61K 39/395 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 31/573 (2013.01); A61K 31/165 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/19 (2013.01); A61K 31/404 (2013.01); A61K 31/437 (2013.01); A61K 31/4402 (2013.01); A61K 38/07 (2013.01); A61K 38/12 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); G01N 33/5011 (2013.01);
Abstract
A pharmaceutical composition comprises a HDAC inhibitor, a pharmaceutically acceptable acid or a salt thereof or a mixture thereof and a steroid or a pharmaceutically acceptable salt thereof as well use of said pharmaceutical composition for the treatment of cancer as a pretreatment prior to other treatments. Said HDAC inhibitor or steroid may alternatively be administrated separately prior to additional treatments.